SCHEMBL2467752

SCHEMBL2467752

Oc1ccc(C/C=C/c2ccccc2)cc1-c1cc(C/C=C/c2ccccc2)ccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
GABRA1 P14867 3/20 0.53
GABRB2 P47870 3/20 0.53
CNR1 P21554 3/20 0.53
CNR2 P34972 3/20 0.53
GAA P10253 2/20 0.53
ALDH2 P05091 1/20 0.53
AKR1B1 P15121 1/20 0.53
HPGD P15428 1/20 0.53
PPARG P37231 1/20 0.53
PPARD Q03181 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
RECQL P46063 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2467754 1.00 MAPT (0.53) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL11697084 0.92 BACE1 (0.54) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL11697081 0.92 BACE1 (0.54) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL9744309 0.88 IDH1 (0.52) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL9744306 0.88 IDH1 (0.52) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL24075808 0.85 MAPT (0.52) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL11697629 0.83 ESR1 (0.50) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL11697621 0.83 ESR1 (0.50) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL11790930 0.80 ALDH1A1 (0.66) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL11579939 0.80 ALDH1A1 (0.45) MAPTKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8519197-B2 Synthesis of magnolol and its analogue compounds COLGATE-PALMOLIVE COMPANY (US) 2013-08-27 US disclosed
US-8519197-B2 Synthesis of magnolol and its analogue compounds COLGATE-PALMOLIVE COMPANY (US) 2013-08-27 US disclosed
US-8519197-B2 Synthesis of magnolol and its analogue compounds COLGATE-PALMOLIVE COMPANY (US) 2013-08-27 US disclosed
US-20120302647-A1 SYNTHESIS OF MAGNOLOL AND ITS ANALOGUE COMPOUNDS INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY (IN) 2012-11-29 US disclosed
US-20120302647-A1 SYNTHESIS OF MAGNOLOL AND ITS ANALOGUE COMPOUNDS INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY (IN) 2012-11-29 US disclosed
US-20120302647-A1 SYNTHESIS OF MAGNOLOL AND ITS ANALOGUE COMPOUNDS INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY (IN) 2012-11-29 US disclosed
WO-2011106003-A1 SYNTHESIS OF MAGNOLOL AND ITS ANALOGUE COMPOUNDS COLGATE-PALMOLIVE COMPANY (US) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302647-A1 SYNTHESIS OF MAGNOLOL AND ITS ANALOGUE COMPOUNDS CYP11B2, CYP11B1, ADRB2 MAPT 1880/4885KDM4E 1987/4885ALDH1A1 1659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.